Phosphorylated forms of activated caspases are present in cytosol from HL-60 cells during etoposide-induced apoptosis

Blood

Volumn 92, Issue 9, 1998, Pages 3042-3049

  Martins, Luis M ^b   Kottke, Timothy J ^b   Kaufmann, Scott H ^b   Earnshaw, William C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLGLUTAMYLVALINYLASPARTYL 7 AMINO 4 TRIFLUOROMETHYLCOUMARIN; CASPASE; COUMARIN DERIVATIVE; CYSTEINE PROTEINASE; ETOPOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATASE; PHOSPHOPROTEIN; PHOSPHORUS 32; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; ISOELECTRIC POINT; LEUKEMIA CELL; PRIORITY JOURNAL;

EID: 0032211157     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3042     Document Type: Article

References (63)

1. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
2. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
3. Villa P, Kaufmann SH, Earnshaw WC: Caspases and caspase inhibitors. Trends Biochem Sci 22:388, 1997
4. Li P, Nijhawan D, Budihardjo I, Sirnivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997
5. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES: Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1:949, 1998
6. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM: An induced proximity model for caspase-8 activation. J Biol Chem 273:2926, 1998
7. Lavin MF, Watters D, Song Q: Role of protein kinase activity in apoptosis. Experientia 52:979, 1996
8. Anderson P: Kinase cascades regulating entry into apoptosis. Microbiol Mol Biol Rev 61:33, 1997
9. Downward J: Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10:262, 1998
10. Uckun FM, Waddick KG, Mahajan S, Jun X, Takara M, Bolen J, Kurosaki T: BTK as a mediator of radiation-induced apoptosis in DT-40 lymphoma cells. Science 273:1096, 1996
11. Emoto Y, Manome Y, Meinhardt G, Kisaki H, Kharbanda S, Robertson M, Ghayur T, Wong W, Kamen R, Weichselbaum R, Kufe D: Proteolytic activation of protein kinase C δ by an ICE-like protease in apoptotic cells. EMBO J 14:6148, 1995
12. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275:90, 1997
13. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon Li, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75, 1996
14. Goillot E, Raingeaud J, Ranger A, Tepper RI, Davis RJ, Harlow E, Sanchez I: Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc Natl Acad Sci USA 94:3302, 1997
15. Xia ZG, Dickens M, Raingeaud J, Davis RJ, Greenbere ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326, 1995
16. Saleem A, Datta R, Yuan ZM, Kharbanda S, Kufe D: Involvement of stress-activated protein kinase in the cellular response to 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents. Cell Growth Differ 6:1651, 1995
17. Chauhan D, Kharbanda S, Ogata A, Urashima M, Teoh G, Robertson M, Kufe DW, Anderson KC: Interleukin-6 inhibits Fas-induced apoptosis and stress-activated protein kinase activation in multiple myeloma cells. Blood 89:227, 1997
18. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosis. Cancer Res 53:3976, 1993
19. Weil M, Jacobson MD, Coles HSR, Davies TJ, Gardner RL, Raff KD, Raff MC: Constitutive expression of the machinery for programmed cell death. J Cell Biol 133:1053, 1996
20. Kawai T, Matsumoto M, Takeda K, Sanjo H, Akira S: ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. Mol Cell Biol 18:1642, 1998
21. Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi A: Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev 9:15, 1994
22. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO-I (CD95) in yeast and causes cell death. Cell 81:513, 1995
23. Hsu HL, Huang JN, Shu HB, Baichwal V, Goeddel DV: TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4:387, 1996
24. Duan H, Dixit VM: RAIDD is a new 'death' adaptor molecule. Nature 385:86, 1997
25. Thome M, Hofmann K, Martinen F, Bodmer J-L, Mattmann C, Tschopp J: Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr Biol 8:885, 1998
26. McCarthy JV, Ni J, Dixit VM: RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem 273:16968, 1998
27. Hofmann K, Bucher P, Tschopp J: The CARD domain: A new apoptotic signaling motif. Trends Biochem Sci 22:155, 1997
28. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ: Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83:2038, 1994
29. Martins LM, Mesner PW, Kottke TJ, Basi GS, Sinha S, Tung JS, Svingen PA, Madden BJ, Takahashi A, McCormick DJ, Earnshaw WC, Kaufmann SH: Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 90:4283, 1997
30. Amarante-Mendes GP, Naekyung-Kim C, Liu L, Huang Y, Perkins CL, Green DR, Bhalla K: Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 91:1700, 1998
31. Dubrez L, Eymin B, Sordet O, Droin N, Turhan AG, Solary E: BCR-ABL delays apoptosis upstream of procaspase-3 activation. Blood 91:2415, 1998
32. Songyang Z, Baltimore D, Cantley LC, Kaplan DR, Franke TF: Interleukin 3-dependent survival by the Akt protein kinase. Proc Natl Acad Sci USA 94:11345, 1997
33. Ahmed NN, Grimes HL, Bellacosa A, Chan TO, Tsichlis PN: Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci USA 94:3627, 1997
34. Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J: Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 16:2783, 1997
35. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3:614, 1997
36. Chen CY, Faller DV: Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J Biol Chem 271:2376, 1996
37. Takahiko I, Xingming D, Carr B, May WS: Bcl-2 Phosphorylation required for anti-apoptosis function. J Biol Chem 272:11671, 1997
38. Haldar S, Jena N, Croce CM: Inactivation of Bcl-2 by phosphorylation. Proc Natl Acad Sci USA 92:4507, 1995
39. Ibrado AM, Liu L, Bhalla K: Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res 57:1109, 1997
40. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME: Akt Phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231, 1997
41. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G: Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687, 1997
42. Gajewski TF, Thompson CB: Apoptosis meets signal transduction: Elimination of a BAD influence. Cell 87:619, 1996
43. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ: Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3, not Bel-XL. Cell 87:619, 1996
44. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with FAS. Science 268:411, 1995
45. Dou QP, An B, Will PL: Induction of a retinoblastoma phosphatase activity by anticancer drugs accompanies p53-independent G1 arrest and apoptosis. Proc Natl Acad Sc USA 92:9019, 1995
46. Morana SJ, Wolf CM, Li JF, Reynolds JE, Brown MK, Eastman A: The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis. J Biol Chem 271:18263, 1996
47. Wolf CM, Reynolds JE, Morana SJ, Eastman A: The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. Exp Cell Res 230:22, 1997
48. Martins LM, Kottke T, Mesner PW, Basi GS, Sinha S, Frigon NJ, Tatar E, Tung JS, Bryant K, Takahashi A, Svingen PA, Madden BJ, McCormick DJ, Earnshaw WC, Kaufmann SH: Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 human leukemia cells during etoposide-induced apoptosis. J Biol Chem 272:7421, 1997
49. Faleiro L, Kobayashi R, Fearnhead H, Lazebnik Y: Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J 16:2271, 1997
50. Lazebnik YA, Cole S, Cooke CA, Nelson WG, Earnshaw WC: Nuclear events of apoptosis in vitro in cell-free mitotic extracts: A model system for analysis of the active phase of apoptosis. J Cell Biol 123:7, 1993
51. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
52. Westermeier R: Electrophoresis in Practice. Weinhelm, Germany, VCH, 1997
53. Cohen GM: Caspases: The executioners of apoptosis. Biochem J 326:1, 1997
54. Takahashi A, Alnemri E, Lazebnik YA, Fernandas-Alnemri T, Litwack G, Moir RD, Goldman RD, Poirer GG, Kaufmann SH, Earnshaw WC: Cleavage of lamin A by Mch2α but not CPP32: Multiple ICE-related proteases with distinct substrate recognition properties are active in apoptosis. Proc Natl Acad Sci USA 93:8395, 1996
55. Rotonda J, Nicholson DW, Fazil KM, Gallant M, Gareau Y, Labelle M, Peterson EP, Rasper DM, Ruel R, Vaillancourt JP, Thornberry NA, Becker JW: The three-dimensional structure of apopain/ CPP32, a key mediator of apoptosis. Nature Struct Biol 3:619, 1996
56. Ghayur T, Hugunin M, Talanian RV, Ratnofsky S, Quinlan C, Emoto Y, Pandey P, Datta R, Huang Y, Kharbanda S, Allen H, Kamen R, Wong W, Kufe D: Proteolytic activation of protein kinase C delta by an ICE/CED 3-like protease induces characteristics of apoptosis. J Exp Med 184:2399, 1996
57. Datta R, Kojima H, Yoshida K, Kufe D: Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J Biol Chem 272:20317, 1997
58. Shimizu T, Cao CX, Shao RG, Pommier Y: Lamin B phosphorylation by protein kinase C alpha and proteolysis during apoptosis in human leukemia HL-60 cells. J Biol Chem 273:8669, 1998
59. Shao RG, Cao CX, Pommier Y: Activation of PKCalpha downstream from caspases during apoptosis induced by 7-hydroxystaurosporine or the topoisomerase inhibitors, camptothecin and etoposide, in human myeloid leukemia HL-60 cells. J Biol Chem 272:31321, 1997
60. Samejima K, Svingen PA, Basi GS, Kottke T, Mesner PWJ, Stewart L, Durrieu F, Poirier GG, Alnemri ES, Champoux JJ, Kaufmann SH, Earnshaw WC: Caspase-mediated cleavage of DNA topoisomerase I at unconventional sites during apoptosis. (manuscript submitted).
61. Ruff VA, Leach KL: Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody. J Biol Chem 270:22602, 1995
62. Darnell JEJ, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415, 1994
63. Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Silvennoinen O: Signaling through the hematopoietic cytokine receptors. Annu Rev Immunol 13:369, 1995